A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA
Cancer is the leading cause of death worldwide. Tumors consist of heterogeneous cell populations that have different biological properties. While conventional cancer therapy such as chemotherapy, radiotherapy, and surgery does not target cancer cells specifically, gene therapy is attracting increasi...
Saved in:
Main Authors: | Ioana Toma (Author), Alina Silvia Porfire (Author), Lucia Ruxandra Tefas (Author), Ioana Berindan-Neagoe (Author), Ioan Tomuță (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DROSHA Knockout Leads to Enhancement of Viral Titers for Vectors Encoding miRNA-Adapted shRNAs
by: Hee Ho Park, et al.
Published: (2018) -
Discovering Cancer-Related miRNAs from miRNA-Target Interactions by Support Vector Machines
by: Cong Pian, et al.
Published: (2020) -
Regulation of miRNA content. Part 1. Editing miRNA. Тailing miRNA
by: A.E. Abaturov, et al.
Published: (2021) -
MiRNA biogenesis. Part 1. Maturation of pre-miRNA. Maturation of canonical miRNAs
by: A.E. Abaturov, et al.
Published: (2021) -
Development of a Curcumin-Loaded Polymeric Microparticulate Oral Drug Delivery System for Colon Targeting by Quality-by-Design Approach
by: Dana Hales, et al.
Published: (2020)